1. Home
  2. PLUR vs TC Comparison

PLUR vs TC Comparison

Compare PLUR & TC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • TC
  • Stock Information
  • Founded
  • PLUR 2001
  • TC 2010
  • Country
  • PLUR Israel
  • TC China
  • Employees
  • PLUR N/A
  • TC N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • TC Business Services
  • Sector
  • PLUR Health Care
  • TC Consumer Discretionary
  • Exchange
  • PLUR Nasdaq
  • TC Nasdaq
  • Market Cap
  • PLUR 36.9M
  • TC 31.8M
  • IPO Year
  • PLUR N/A
  • TC 2018
  • Fundamental
  • Price
  • PLUR $3.95
  • TC $16.50
  • Analyst Decision
  • PLUR Strong Buy
  • TC
  • Analyst Count
  • PLUR 1
  • TC 0
  • Target Price
  • PLUR $12.00
  • TC N/A
  • AVG Volume (30 Days)
  • PLUR 52.1K
  • TC 8.7K
  • Earning Date
  • PLUR 11-12-2025
  • TC 12-16-2025
  • Dividend Yield
  • PLUR N/A
  • TC N/A
  • EPS Growth
  • PLUR N/A
  • TC N/A
  • EPS
  • PLUR N/A
  • TC N/A
  • Revenue
  • PLUR $1,326,000.00
  • TC $5,115,721.00
  • Revenue This Year
  • PLUR $97.38
  • TC N/A
  • Revenue Next Year
  • PLUR $293.97
  • TC N/A
  • P/E Ratio
  • PLUR N/A
  • TC N/A
  • Revenue Growth
  • PLUR 121.74
  • TC N/A
  • 52 Week Low
  • PLUR $3.22
  • TC $9.20
  • 52 Week High
  • PLUR $7.13
  • TC $39.00
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 48.02
  • TC 44.36
  • Support Level
  • PLUR $3.50
  • TC $17.00
  • Resistance Level
  • PLUR $4.12
  • TC $18.58
  • Average True Range (ATR)
  • PLUR 0.37
  • TC 1.36
  • MACD
  • PLUR 0.03
  • TC -0.32
  • Stochastic Oscillator
  • PLUR 36.83
  • TC 10.24

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About TC TuanChe Limited

Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.

Share on Social Networks: